Biogen Inc. (BIT:1BIIB)
103.80
-0.25 (-0.24%)
At close: Apr 16, 2025, 5:30 PM CET
Biogen Revenue
In the year 2024, Biogen had annual revenue of $9.68B USD, down -1.62%. Biogen had revenue of $2.45B in the quarter ending December 31, 2024, with 2.87% growth.
Revenue
$9.68B
Revenue Growth
-1.62%
P/S Ratio
1.63
Revenue / Employee
$1.27M
Employees
7,605
Market Cap
15.27B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.68B | -159.70M | -1.62% |
Dec 31, 2023 | 9.84B | -337.80M | -3.32% |
Dec 31, 2022 | 10.17B | -808.30M | -7.36% |
Dec 31, 2021 | 10.98B | -2.46B | -18.32% |
Dec 31, 2020 | 13.44B | -933.30M | -6.49% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UniCredit | 23.99B |
Intesa Sanpaolo | 25.38B |
Enel SpA | 78.95B |
Ferrari | 6.68B |
Assicurazioni Generali | 55.30B |
Eni S.p.A. | 91.17B |
Leonardo S.p.a. | 17.76B |
Stellantis | 156.88B |